Entry |
Concentration
Used |
% Growth of Inhibition |
Entry |
Concentration
Used |
% Growth of Inhibition |
3a |
10 ug/mL |
9.84 |
3l |
10 ug/mL |
68.88 |
3b |
10 ug/mL |
71.23 |
3m |
10 ug/mL |
83.34 |
3c |
10 ug/mL |
85.53 |
3n |
10 ug/mL |
33.14 |
3d |
10 ug/mL |
29.51 |
3o |
10 ug/mL |
9.58 |
3e |
10 ug/mL |
71.95 |
3p |
10 ug/mL |
54.22 |
3f |
10 ug/mL |
25.57 |
3q |
10 ug/mL |
51.41 |
3g |
10 ug/mL |
85.03 |
3r |
10 ug/mL |
15.41 |
3h |
10 ug/mL |
13.06 |
3s |
10 ug/mL |
10.40 |
3i |
10 ug/mL |
67.53 |
3t |
10 ug/mL |
5.80 |
3j |
10 ug/mL |
19.34 |
Nifurtimox |
10 ug/mL |
68.50 |
3k |
10 ug/mL |
23.32 |
Benznidazole |
10 ug/mL |
86.77 |
*Each value is the mean of three experiments |
